As of Feb 26
| +0.0207 / +2.66%|
The 2 analysts offering 12-month price forecasts for Rexahn Pharmaceuticals Inc have a median target of 3.25, with a high estimate of 3.50 and a low estimate of 3.00. The median estimate represents a +306.25% increase from the last price of 0.80.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.